Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Medifast, Inc. stacks up to the competition and put relevant competitor and industry information at your fingertips.
Corporate Events, Jason Enterprises, Jason Pharmaceuticals, Jason Properties, Medifast Franchise Systems, OPTAVIA, Seven Crondall Associates
Medifast is a public company headquartered in Maryland with an estimated 634 employees. In the US, the company has a notable market share in at least two industries: Weight Loss Services, Online Weight Loss Services and Online Weight Loss Services. Their largest market share is in the Weight Loss Services industry, where they account for an estimated 29.5% of total industry revenue and are considered an All Star because they display stronger market share, profit and revenue growth compared to their peers.
Of the 4 core revenue-generating products and services in the Weight Loss Services industry, Medifast, Inc. offers:
Of the 2 core revenue-generating products and services in the Online Weight Loss Services industry, Medifast, Inc. offers:
Strengths and weaknesses take into account internal factors, and are based on Medifast, Inc.'s performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Weight Loss Services , Online Weight Loss Services industries
Gain strategic insight and analysis on 700+ in the United States industries
(& thousands of global industries)
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Revenue | 501.0 | 713.7 | 934.8 | 1,526.1 | 1,598.6 | 1,072.1 |
Cost of Revenue | ||||||
Cost of Revenue, Non-Cash | ||||||
Gross Profit | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Cash and Equivalents | 81.4 | 77.0 | 163.7 | 104.2 | 87.7 | 94.4 |
Short-Term Investments | ||||||
Derivative Assets, Current | ||||||
Restricted Cash and Investments | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Net Income | N/A | N/A | N/A | N/A | N/A | N/A |
Income (Loss) From Discontinued Operations | ||||||
Depreciation, Depletion and Amortization | ||||||
Amortization of Financing Costs and Discounts | ||||||
00000 |
IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.